0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Invited Commentary | 
June K. Robinson, MD
JAMA Intern Med. 2014;174(6):970-971. doi:10.1001/jamainternmed.2014.157.

Original Investigation | 
Wen-Qing Li, PhD; Abrar A. Qureshi, MD, MPH; Kathleen C. Robinson, PhD; et al.
JAMA Intern Med. 2014;174(6):964-970. doi:10.1001/jamainternmed.2014.594.
Includes: Supplemental Content

Invited Commentary | 
Eleni Linos, MD, DrPH
Arch Intern Med. 2012;172(12):907. doi:10.1001/archinternmed.2012.1905.

Perspectives |  FREE
Mignon F. Benjamin, MD; Paul Froom, MD
Arch Intern Med. 2012;172(12):906. doi:10.1001/archinternmed.2012.1246.

Research Letters |  FREE
Alina Markova, BA; Martin A. Weinstock, MD, PhD; Patricia Risica, PhD; et al.
Arch Intern Med. 2011;171(22):2061-2063. doi:10.1001/archinternmed.2011.592.

Editor's Correspondence | 
Marko Lens, MD, PhD, FRCS
Arch Intern Med. 2011;171(18):1686-1687. doi:10.1001/archinternmed.2011.483.

Editor's Correspondence | 
Vincenzo De Giorgi, MD; Marta Grazzini, MD; Sara Gandini, PhD; et al.
Arch Intern Med. 2011;171(18):1686-1687. doi:10.1001/archinternmed.2011.484.

Clinical Observation | 
Vincenzo De Giorgi, MD; Marta Grazzini, MD; Sara Gandini, PhD; et al.
Arch Intern Med. 2011;171(8):779-781. doi:10.1001/archinternmed.2011.131.

Original Investigation |  FREE
Abrar A. Qureshi, MD, MPH; Francine Laden, ScD; Graham A. Colditz, MD, DrPH; et al.
Arch Intern Med. 2008;168(5):501-507. doi:10.1001/archinte.168.5.501.

Original Investigation |  FREE
Janice N. Cormier, MD, MPH; Yan Xing, MD; Meichun Ding, PhD; et al.
Arch Intern Med. 2006;166(17):1907-1914. doi:10.1001/archinte.166.17.1907.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
Related JAMA Internal Medicine Collections
From The JAMA Network
JAMA Oncology
Editorial  | 
Broad Applicability of Nivolumab in Melanoma Regardless of BRAF Mutation Status
Tara C. Gangadhar, MD; Lynn M. Schuchter, MD
JAMA Oncology
From The JAMA Network  | 
Why Do Airline Pilots and Flight Crews Have an Increased Incidence of Melanoma?
Erica Shantha, MD; Chris Lewis, BS; Paul Nghiem, MD, PhD
JAMA Oncology
Original Investigation  | 
Efficacy and Safety of Nivolumab in Patients With BRAF V600 Mutant and BRAF Wild-Type Advanced Melanoma:  A Pooled Analysis of 4 Clinical Trials
James Larkin, MD, PhD; Christopher D. Lao, MD, MPH; Walter J. Urba, MD, PhD; et al.
JAMA Oncology
Review  | 
Clinical Management of Multiple Melanoma Brain Metastases:  A Systematic Review
Sharad Goyal, MD; Ann W. Silk, MD, MS; Sibo Tian, BA; et al.